Hopes and failures in front-line advanced HER2-positive gastric cancer therapy

Kong, FM; Yao, Y; Deng, RF; Li, XJ; Jia, YJ

Jia, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Dept Oncol, Teaching Hosp 1, Anshanxi Rd, Tianjin 300193, Peoples R China.

ANTI-CANCER DRUGS, 2021; 32 (7): 675

Abstract

Human epidermal growth-factor receptor 2 (HER2) was an important therapeutic target in gastric cancer. Through the last decade, strategy with trastuzu......

Full Text Link